Trial Profile
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Sertraline
- Indications Social phobia
- Focus Therapeutic Use
- 02 Jun 2011 Status changed from active, no longer recruiting to completed, based on presentation of results.
- 25 Oct 2010 New trial record